Anyone who missed Carlo Montagner's appearance at yesterday's public hearing of the parliamentary inquiry into approval processes for new drugs and novel medical technologies should find a way to watch what was a 'masterclass' in the presentation of the industry's issues with decision-making. …
A 'case study' in how to present the industry's perspective
April 23, 2021 Latest NewsBioPharmaComment
Latest Video
New Stories
-
Moderna taps Salesforce to unify global commercial operations
April 30, 2026 - - Latest News -
How do we know the HTA institution loves patients? Because they use a love heart emoji
April 30, 2026 - - Latest News -
Australian company secures capital raise to advance amsulostat trials and strengthen pipeline
April 29, 2026 - - Latest News -
Australia urged to strengthen sunscreen literacy and label clarity
April 29, 2026 - -
'Let me once again explain why we must close the gap for people with cystic fibrosis–related diabetes'
April 29, 2026 - - Latest News -
We need to say it again, just in case, that this advice is about ministerial choices and not conditions
April 29, 2026 - - Latest News -
Families welcome cancer drug progress but remain cautious over timely access
April 28, 2026 - - Latest News